Effectiveness of long-term infliximab use and impact of treatment adherence on disease control in refractory, non-infectious pediatric uveitis.
Virginia Miraldi UtzSabrina BulasSarah LopperMatthew FenchelTing SaMitul MehtaDaniel AshDaniel J LovellAdam H KaufmanPublished in: Pediatric rheumatology online journal (2019)
This study adds significantly to the IFX literature by documenting outstanding uveitis control with long-term IFX treatment in non-infectious pediatric uveitis patients. Higher dosage and shorter interval were utilized without adverse effects. Importantly, this is the first study, to our knowledge, to document the significant impact of treatment adherence on uveitis control.